PRESS RELEASE published on 03/25/2025 at 10:26, 1 year 5 months ago Informations privilégiées / Autres communiqués Arkema déclare les transactions sur actions propres du 17 au 21 mars 2025 selon la réglementation en vigueur. Voir détails sur le site web d'Arkema Actions Propres Transactions Réglementation ARKEMA Détails
PRESS RELEASE published on 03/25/2025 at 10:26, 1 year 5 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 17 to 21 March 2025, following regulations. Total daily volume 26,000 shares, weighted average price 79.6127. More info on Arkema's website Share Buyback Trading Regulation ARKEMA Weighted Average Price
BRIEF published on 03/18/2025 at 11:16, 1 year 5 months ago Achat d'actions propres par Arkema : résumé des transactions du 10 au 14 mars 2025 Transactions Boursières Réglementation UE Achat D'actions ARKEMA Mars 2025
BRIEF published on 03/18/2025 at 11:16, 1 year 5 months ago Purchase of own shares by Arkema: summary of transactions from March 10 to 14, 2025 EU Regulations Purchase Of Shares ARKEMA Stock Market Transactions March 2025
PRESS RELEASE published on 03/18/2025 at 11:11, 1 year 5 months ago Informations privilégiées / Autres communiqués Arkema déclare les achats d'actions propres du 10 au 14 mars 2025, conformément à la réglementation. Plus de détails sur le site web d'Arkema Actions Propres Transactions Réglementation Achats ARKEMA
PRESS RELEASE published on 03/18/2025 at 11:11, 1 year 5 months ago Inside Information / Other news releases Arkema discloses own shares trading details from 10-14 March 2025 in compliance with regulations. Visit website for full info Shares Trading Regulation Buybacks ARKEMA
BRIEF published on 03/10/2025 at 15:30, 1 year 6 months ago Franchissement de seuil par BlackRock dans Arkema Capital Franchissement De Seuil Actions BlackRock ARKEMA
BRIEF published on 03/10/2025 at 15:30, 1 year 6 months ago BlackRock Crosses Threshold in Arkema Capital Actions BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 03/10/2025 at 15:25, 1 year 6 months ago Franchissement de seuil Le gestionnaire d'investissement BlackRock Inc. a déclaré dépasser 5% du capital de ARKEMA avec 3 978 835 actions, résultant d'une acquisition sur le marché et d'actions détenues à titre de collatéral BlackRock Inc. ARKEMA 5% Gestionnaire D'investissement Déclaration Franchissement Seuil
BRIEF published on 03/10/2025 at 13:04, 1 year 6 months ago BlackRock baisse sa participation dans ARKEMA Actions Participation BlackRock Gestion D'actifs ARKEMA
Published on 09/11/2026 at 04:00, 7 hours 13 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 48 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 53 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 13 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 57 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 52 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 7 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 13 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 13 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 13 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 13 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 43 minutes ago Availability of the 2026 Interim Financial Report
